0000899243-22-029864.txt : 20220826
0000899243-22-029864.hdr.sgml : 20220826
20220826163058
ACCESSION NUMBER: 0000899243-22-029864
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220705
FILED AS OF DATE: 20220826
DATE AS OF CHANGE: 20220826
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Menzel Garry E
CENTRAL INDEX KEY: 0001556064
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38811
FILM NUMBER: 221205662
MAIL ADDRESS:
STREET 1: C/O REGULUS THERAPEUTICS INC.
STREET 2: 3545 JOHN HOPKINS COURT SUITE 210
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TCR2 THERAPEUTICS INC.
CENTRAL INDEX KEY: 0001750019
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 474152751
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-949-5200
MAIL ADDRESS:
STREET 1: 100 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-07-05
0
0001750019
TCR2 THERAPEUTICS INC.
TCRR
0001556064
Menzel Garry E
C/O TCR2 THERAPEUTICS
100 BINNEY STREET
CAMBRIDGE
MA
02142
1
1
0
0
President & CEO
Common Stock
2022-07-05
4
G
0
84527
0.00
D
0
I
See Footnote
Common Stock
2022-07-05
4
G
0
84527
0.00
A
84527
I
See Footnote
Common Stock
2022-07-05
4
G
0
48202
0.00
D
132730
D
Common Stock
2022-07-05
4
G
0
48202
0.00
A
132729
I
See Footnote
Common Stock
2022-07-05
4
G
0
132730
0.00
D
0
D
Common Stock
2022-07-05
4
G
0
132730
0.00
A
132730
I
See Footnote
The reporting person is voluntarily reporting the disposition for no consideration on July 5, 2022 of 84,527 shares of common stock held by the reporting person, as Trustee of the Garry E. Menzel and Mary E. Henshall Family Trust, under instrument of trust dated July 29, 2010, to the Garry E. Menzel Revocable Trust of 2022, under Indenture of Trust dated April 45, 2022 (the "Menzel Trust"). The reporting person is the trustee of the Menzel Trust and may be deemed to beneficially own these securities. The reporting person and members of his immediate family are the sole beneficiaries of the Menzel Trust.
The reporting person is voluntarily reporting the disposition for no consideration on July 5, 2022 of 48,202 shares of common stock held by the reporting person to the Menzel Trust.
The reporting person is voluntarily reporting the disposition for no consideration on July 5, 2022 of 132,730 shares of common stock held by the reporting person to the Mary E. Henshall Revocable Trust of 2022, under Indenture of Trust dated April 5, 2022 (the "Henshall Trust"). The reporting person's spouse is the trustee of the Henshall Trust, and as such the reporting person may be deemed to beneficially own these securities. The reporting person and members of his immediate family are the sole beneficiaries of the Henshall Trust.
Margaret Siegel as Attorney-In-Fact
2022-08-26